Wednesday, July 20, 2011

Article > InterMune's pirfenidone approved in Europe for IPF

Article > InterMune's pirfenidone approved in Europe for IPF


InterMune is celebrating after getting the thumbs-up from regulators in Europe for its idiopathic pulmonary fibrosis treatment Esbriet.

Thanks for the information Carolyn.

Celebrate Life,
Alma

No comments:

Post a Comment